BCMA CAR-T
/ PersonGen Biomedicine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 22, 2020
ASCO Update on Myeloma: How Promising Are BCMA CAR-T & BCMA x CD3 Bispecific T-Cell Therapies?
(VuMedi)
- https://www.vumedi.com/channel/penn-medicine-oncology/tab/2020-updates-in-oncology/video/asco-update-on-myeloma-how-promising-are-bcma-car-t-bcma-x-cd3-bispecific-t-cell-therapies/
Video
1 to 1
Of
1
Go to page
1